Relationship of PTTG expression with tumor invasiveness and microvessel density of pituitary adenomas: A meta-analysis

Genetic Testing and Molecular Biomarkers

Volumn 18, Issue 4, 2014, Pages 279-285

  Li, Yan ^a   Zhou, Li Ping ^a   Ma, Ping ^a   Sui, Cheng Guang ^a   Meng, Fan Dong ^a   Tian, Xin ^a   Fu, Li Ye ^a   Jiang, You Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PITUITARY TUMOR TRANSFORMING GENE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CAPILLARY DENSITY; CARCINOGENESIS; CINAHL; COCHRANE LIBRARY; COHORT ANALYSIS; COMPUTER PROGRAM; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; GENE; HUMAN; HYPOPHYSIS ADENOMA; MEDLINE; META ANALYSIS; PROTEIN EXPRESSION; RISK; SENSITIVITY ANALYSIS; TUMOR INVASION; GENETICS; HYPOPHYSIS TUMOR; PATHOLOGY; VASCULARIZATION;

HUMANS; NEOPLASM INVASIVENESS; PITUITARY NEOPLASMS;

EID: 84897528797     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0447     Document Type: Article

References (50)

1. Biggerstaff BJ, Jackson D (2008) The exact distribution of Cochran's heterogeneity statistic in one-way random effects meta-analysis. Stat Med 27:6093-6110.
2. Chesnokova V, Kovacs K, Castro AV, et al. (2005) Pituitary hypoplasia in Pttg-/-mice is protective for Rb +/-pituitary tumorigenesis. Mol Endocrinol 19:2371-2379.
3. Chesnokova V, Melmed S (2010) Pituitary senescence: the evolving role of Pttg. Mol Cell Endocrinol 326:55-59.
4. Chesnokova V, Zonis S, Rubinek T, et al. (2007) Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res 67:10564-10572.
5. Chesnokova V, Zonis S, Zhou C, et al. (2011) Lineage-specific restraint of pituitary gonadotroph cell adenoma growth. PLoS One 6:e17924.
6. Cristina C, Diaz-Torga GS, Goya RG, et al. (2007) PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes. Mol Cancer 6:4.
7. Cruz-Soto ME, Scheiber MD, Gregerson KA, et al. (2002) Pituitary tumorigenesis in prolactin gene-disrupted mice. Endocrinology 143:4429-4436.
8. Cuny T, Pertuit M, Sahnoun-Fathallah M, et al. (2013) Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis. Eur J Endocrinol 168:533-541.
9. Daly AF, Rixhon M, Adam C, et al. (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91:4769-4775.
10. Dolecek TA, Propp JM, Stroup NE, et al. (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14:v1-v49.
11. Donangelo I, Gutman S, Horvath E, et al. (2006) Pituitary tumor transforming gene overexpression facilitates pituitary tumor development. Endocrinology 147:4781-4791.
12. Dupont WD, Plummer WD, Jr. (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11:116-128.
13. Ezzat S, Asa SL, Couldwell WT, et al. (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613-619.
14. Fedele M, Fusco A (2013) Pituitary adenoma: role of HMGA proteins. Tumour Cent Nerv Syst 10:161-168.
15. Filippella M, Galland F, Kujas M, et al. (2006) Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin Endocrinol (Oxf) 65:536-543.
16. Gadelha MR, Trivellin G, Hernandez Ramirez LC, et al. (2013) Genetics of pituitary adenomas. Front Horm Res 41:111-140.
17. Gagliano T, Filieri C, Minoia M, et al. (2013) Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. Pituitary 16:91-100.
18. He XL, Xia ZX, Zhang HB, et al. (2008) A study of the relationship between the expression of PTTG, survivin and P53 and the biological behavior in pituitary adenomas. Mod Pract Med 20:588-590, 604.
19. Hsueh C, Lin JD, Chang YS, et al. (2013) Prognostic significance of pituitary tumour-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma. Clin Endocrinol (Oxf) 78:303-309.
20. Hu JF, Su Q, Cai Y (2006) Expression of pituitary tumor transforming gene in pituitary macroadenomas and ots relationship with tumor invasiveness. J Shanghai Jiaotong Univ (Med Scie) 26:193-195.
21. Jaffrain-Rea M-L, Beckers A (2013) The role of aryl hydrocarbon receptor (AHR) and AHR-interacting protein (AIP) in the pathogenesis of pituitary adenomas. Tumour Cent Nerv Syst 10:189-201.
22. Li AJ, Wang DK, Wang YH, et al. (2007) Expressions of pituitary tumor transforming gene and matrix metalloproteinases in pituitary adenomas and their meanings. Chin J Clin Neurosurg 12:418-421.
23. Li J, Niu CS, Ding M (2008) Expressions and significance of Letin, PTTG and Ki67 in incasive pituitary adenomas. Chin J Minim Invasive Neurosurg 13:71-74.
24. Li YY, Li MH, Xiong ZY (2006) Expression of PTTG and Cmyc in pituitary adenoma and its relation to tumor recurrence. Pract Clin Med 7:10-12.
25. Liu JN, Liu YS, Nie XM (2004) The relationship between PTTG,p16 and cyclinD1 expression with invasiveness of pituitary adenomas. Chin J Minim Invasive Neurosurg 9:172-175.
26. McCabe CJ, Khaira JS, Boelaert K, et al. (2003) Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin Endocrinol (Oxf) 58:141-150.
27. Melmed S (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112:1603-1618.
28. Mo K, Fu DH, Wang ZF (2011) Correlation analysis between the expressions of PTTG and VEGF and the malignant invasive grade in pituitary adenomas. J Minim Invasive Med 6:94-96.
29. Peters JL, Sutton AJ, Jones DR, et al. (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676-680.
30. Raverot G, Wierinckx A, Dantony E, et al. (2010) Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. J Clin Endocrinol Metab 95:1708-1716.
31. Recouvreux MV, Lapyckyj L, Camilletti MA, et al. (2013) Sex differences in the pituitary transforming growth factor-b1 (TGF-b1) system. Studies in a model of resistant prolactinomas. Endocrinology 154:4192-4205.
32. Shah PP, Kakar SS (2011) Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin. Cancer Lett 311:66-76.
33. Shen YL, Cui YT (2012) Expression of pituitary tumor transforming gene(PTTG) protein and relations to cell proliferation and invasion in pituitary adenomas. Anat Res 34:202-205.
34. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603-605.
35. Sun HL, Cui YL, Xing SZ (2013) Association of PTTG expression and microvessel density with tumor invasiveness in elder patients with pituitary adenoma. Chin J Gerontol 33: 176-177.
36. Tfelt-Hansen J, Kanuparthi D, Chattopadhyay N (2006) The emerging role of pituitary tumor transforming gene in tumorigenesis. Clin Med Res 4:130-137.
37. Trivellin G, Butz H, Delhove J, et al. (2012) MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. Am J Physiol Endocrinol Metab 303:E708-E719.
38. Vlotides G, Eigler T, Melmed S (2007) Pituitary tumortransforming gene: physiology and implications for tumorigenesis. Endocr Rev 28:165-186.
39. Wang F, Zhang WD, Liu YL, et al. (2005) Expression of PTTG and bFGF protein and their significance in hunan pituitary adenomas. Chin J Clin Neurosurg 10:32-34, 38.
40. Wang YS, Sun LM, Xia JL, et al. (2008) Expression of PTTG and vascular endothelial growth factor in human pituitary adenomas and their relationship to angiogenesis. Chin J Clin Neurosurg 13:279-281.
41. Wu JS, Tian LQ, Su ZP, et al. (2010) Expression of PTTG,Ki-67 and H-ras proteins in pituitary adenomas invading cavernous sinus space. Zhejiang Med J 32:1290-1293.
42. Xiong ZY, Li MH, Li YY (2006) Expression of PCNA, PTTG, c-myc, p53 in pituitary adenomas and their relationship with the adenomas recurrency. Chin J Clin Neurosurg 11:531-534.
43. Ye F, Zhang H, Yang YX, et al. (2011) Comparative proteome analysis of 3T3-L1 adipocyte differentiation using iTRAQcoupled 2D LC-MS/MS. J Cell Biochem 112:3002-3014.
44. Yoon C-H, Kim M-J, Lee H, et al. (2012) PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population. J Biol Chem 287:19516-19527.
45. Yu R, Lu W, Chen J, et al. (2003) Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology 144:4991-4998.
46. Zhang X, Horwitz GA, Prezant TR, et al. (1999) Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol 13:156-166.
47. Zhang Y, Zhang XN, Zhu XB, et al. (2012) The correlativity of PTTG, MMP-2 MMP-9 with the invasiveness of pituitary adenoma. Chin J Lab Diagn 16:1671-1673.
48. Zhou C (2013) Pituitary tumors: role of pituitary tumortransforming gene-1 (PTTG1). Tumors Cent Nerv Syst 10: 203-214.
49. Zhou C, Tong Y, Wawrowsky K, et al. (2013) PTTG acts as a STAT3 target gene for colorectal cancer cell growth and motility. Oncogene 33:851-861.
50. Zhou J, Chen ZB (2008) The correlativity of PTEN, Survivin and PTTG with the invasiveness of pituitary adenoma. J Xianning Univ 22:102-106.